BioSpace News Archive

Paradigm today announced the commercial release of a substantially improved next generation sequencing (NGS) panel for patients with late stage and aggressive cancer.

Startup Receives $350K Grand Prize for Non-Invasive Neuromodulation Device to Treat Patients with Severe Chronic Pain

Helio Training, an organization specializing in software development training, is pleased to announce a new partnership with Larry H. Miller Sports & Entertainment (LHMSE

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that it will redeem $125 million aggregate principal amount of its outstanding 7.50% Senior Notes due 2021, CUSIP Nos. 92912EAA1, C96715AA2 (the “Notes”) on Oct. 26, 2018.

Bardy Diagnostics, Inc. announced it was selected as one of six winners of the “Make Your Medical Device Pitch for Kids!” Competition hosted by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

Upon the passage of the fiscal year (FY) 2019 Healthy and Human Services (HHS) budget with an additional $425 million designated for Alzheimer’s disease research—bringing the federal funding to fight Alzheimer’s to a total of $2.34 billion—The Alzheimer’s Foundation of America (AFA) issued the following statement from Charles J. Fuschillo, Jr., AFA’s president and CEO

Alzheimer’s Research UK, is calling on the UK government to adopt a bold new action plan to bring about a life-changing dementia treatment and improve the lives of people with the condition.